Blogs

Asessing Risk in Biopharma Raw Materials: Actuaries Wanted?

They Herded Us Out Like Cattle: Stories of Job Loss and Coping

Battle in Berkeley: Does Bayer Owe the Bay Area?

Complacent or Overly Compliant? Why Has Industry Been Slow to Adopt Single-Use for Bioprocess Control?

"Ajaz the Avenger" on the Need for Unity: For PAT and QbD, Pharma Must Learn from Bioprocessing

Cell Side Story: Introducing Kenny Twist and D'Na the DNA Girl

Please Take This Survey (and How Many Times Can We Say Thank You?)

Change: It’s Coming (or “I’ll Get Agile… Mañana”)

Chilling Tales of Tech Transfer Gone Terribly Wrong

An iPhone Bioreactor? C’mon, Really?